The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be covered under Medicaid and Medicare for more Americans.

Millions of Americans are diagnosed with obesity, which is considered a chronic disease that can lead to serious health consequences like cardiovascular disease, stroke and diabetes. One recent study found three-quarters of U.S. adults are overweight or obese.

Medicare and Medicaid currently cover the cost of some obesity medication........

© The Hill